A(z) CCO csatorna legjobb podcastjai (2025)

1
How Pharmacists Can Enhance Comprehensive Patient-Centered Care for Patients With HR+/HER2- MBC and Comorbidities 16:41

3d ago16:41

16:41

In this podcast episode, Allison Butts, PharmD, BCOP, reviews how pharmacists can help in providing comprehensive patient-centric care for patients with HR+/HER2- MBC and preexisting comorbid conditions, including: Common comorbidities and complexities in managing patients with HR+/HER2- MBC Treatment landscape for patients with HR+/HER2- MBC Real-…

1
Quality Improvement in Obesity Care: How to Implement Documentation Shortcuts 24:05

16d ago24:05

24:05

Listen in as Joseph Kim, MD, MPH, MBA, interviews Sophia Kwon, MD, to learn about how she implemented a documentation shortcut at her institution to improve obesity care, including: Creating an obesity checklist within the electronic health record Training staff to correctly use this checklist and broach obesity topics with patients Garnering feedb…

1
Overcoming Common Hurdles to RSV Vaccination in Post-acute and Long-term Care 19:59

18d ago19:59

19:59

In this episode, Jewel Mullen, MD, MPH, MPA, and Dallas Nelson, MD, CMD, FACP discuss overcoming barriers to RSV vaccine uptake in post-acute and long-term care facilities, including: How to incorporate the latest RSV vaccination recommendations into clinical practice Practical strategies for navigating insurance Effective and empathetic methods of…

1
The Language of Leadership: Empathy and Cultural Clarity 32:04

19d ago32:04

32:04

As language evolves and workplaces divide, CCOs must lead with empathy and clarity. SHRM CEO Johnny C. Taylor, Jr. joins Page CEO Dr. Rochelle Ford to explore how communicators can craft the unifying language today’s organizations need in a lively fireside chat at our 2025 Spring Seminar.Page Society által

1
The Latest Evidence on Targeting B7-H3 in Small Cell Lung Cancer 18:34

4d ago18:34

18:34

In this episode, hear Lauren Byers, MD and Christine Hann, MD share their insights on the latest data regarding new therapies targeting B7-H3 in small cell lung cancer including: Rationale for targeting B7-H3 Overview of the structure of antibody-drug conjugates (ADCs) Results from the phase I/II IDeate-PanTumor01 trial of ifinatamab deruxtecan (I-…

1
The Lay of the Land: Overview of Biology of HER2 in Genitourinary, Gastrointestinal, and Gynecologic Malignancies 14:09

6d ago14:09

14:09

In this episode, Zev A. Wainberg, MD; Funda Meric-Bernstam, MD; Alexandra Leary, MD, PhD; and Catherine Fahey, MD, PhD, explore testing for HER2 alterations and the incidence of HER2-positive disease in the treatment of genitourinary, gastrointestinal, and gynecologic malignancies. HER2 Testing in Advanced Cancers: Recommendations for when and how …

1
Day of Mourning: Tracey Csordas’ Story 15:54

17d ago15:54

15:54

Threads of Life Ambassador Tracey Csordas’ life changed forever the day her brother died in a preventable workplace tragedy. Hear her powerful story.

1
Climate Change Impacts on Workplace Health and Safety with Dr. Sarah Henderson 11:25

19d ago11:25

11:25

Extreme weather events driven by climate change are happening across Canada with increasing frequency. Dr. Sarah Henderson joins us to discuss the potential impacts on workers and how workplaces can build more climate resiliency.

1
Key HIV Studies Influencing My Practice Following CROI 2025—Dr Chloe Orkin and Dr Jean-Michel Molina 39:03

23d ago39:03

39:03

In this episode, Chloe Orkin, MBChB, FRCP, MD, and Jean-Michel Molina, MD, PhD, discuss highlights from CCO’s independent conference coverage of CROI 2025, including: Advances in HIV treatment based on results from CARES Potential HIV therapies in the pipeline, such as doravirine/islatravir Effects of broadly neutralizing antibodies on HIV treatmen…

1
PR Has a PR Problem—Curtis Sparrer Wrote a Graphic Novel to Fix It 16:44

24d ago16:44

16:44

PR often gets miscast as spin—but Curtis Sparrer wants to change the script. The Page member, PR pro-turned-graphic-novelist, joins us to talk about "Game Face," his new graphic novel that puts public relations in the hero’s seat. What started as a way to explain PR to his niece became a clever crash course for kids, clients and anyone who's ever s…

1
Partnering With Patients for PBC Care: Actionable Strategies for HCPs 13:45

27d ago13:45

13:45

In this episode, Dr Gideon Hirschfield meets with patient advocate Jess Schnur to discuss challenges related to the diagnosis and management of primary biliary cholangitis (PBC) to provide actionable strategies for healthcare professionals to incorporate into patient care, including: Disease concerns and frequently asked questions from a patient pe…

1
The Future of Work with Tyler Waye 14:20

27d ago14:20

14:20

The world around us is changing rapidly – and so is the workplace and what motivates us. Work and leadership strategist Tyler Waye joins us to discuss what employers and workers can do to build the thriving workplaces of the future.

1
Oncologist On-Call: Thoughts on the Current Treatment Landscape for First-line Management of HER2-Positive mBC 14:42

1M ago14:42

14:42

In this episode, listen to Stephanie L. Graff, MD, FACP, FASCO; and Laura M. Spring, MD, share their clinical insights and takeaways regarding the current treatment landscape for first-line treatment of patients with HER2-positive metastatic breast cancer including: Data from multicenter, single-arm, phase IIIb/IV DESTINY-Breast12 evaluating trastu…

1
Debating the Role of ALP Normalization in PBC: Curbside Consults Podcast 21:00

1M ago21:00

21:00

In this podcast, expert faculty, Dr Stuart Gordon and Dr Nancy Reau, use an illustrative patient case to explore the roles of ALP and other biochemical markers in PBC management, and explain what to expect from treatment. Topics covered include: How baseline ALP can affect ALP normalization after second-line treatment with elafibranor and seladelpa…

1
Managing PBC Therapy for Patients With Cirrhosis: Curbside Consults Podcast 16:08

1M ago16:08

16:08

In this podcast, expert faculty, Dr Stuart Gordon and Dr Nancy Reau discuss an illustrative patient case to demonstrate how they individualize primary biliary cholangitis (PBC) therapy for patients with cirrhosis. Topics covered include: AASLD guideline recommendations for second-line therapy for PBC Considerations when using newer agents for seco…

1
Addressing Inequities in Personal Protective Equipment 18:19

1M ago18:19

18:19

When personal protective equipment is designed with diverse body types in mind, everyone in the workplace benefits. Dr. Amin Yazdani joins us to discuss how using breakthrough technology can shape the design of more inclusive PPE for workers in Canada.

1
COVID-19 in EU: Inpatient Treatment Options for Severe COVID-19 in People Who Are Immunocompromised 24:53

2M ago24:53

24:53

Listen in as Cristina Mussini, MD; Martin Witzenrath, MD, FERS; and Michele Bartoletti, MD, PhD, discuss treatment strategies for people who are immunocompromised with COVID-19 in the hospital setting, including: Antiviral therapy with remdesivir Dexamethasone for patients with hematologic malignancies Considerations regarding other immunomodulator…

1
Making AI Work: Lessons from PwC’s Transformation 7:46

2M ago7:46

7:46

In this episode of The New CCO Brief, Megan Noel, former Senior Managing Director for communications and corporate affairs at PwC, shares how change management was the key to unlocking AI’s full potential. From upskilling 75,000 employees to building trust across the organization, she reveals the practical strategies that made AI work at scale—and …

1
Treatment Options for Severe COVID-19 in Patients Who Are Immunocompromised 20:32

2M ago20:32

20:32

In this episode, Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss treatment strategies for people who have severe COVID-19, including: Antiviral therapy with remdesivir Dexamethasone and other systemic corticosteroids Immunomodulators, such as JAK inhibitors or IL-6 inhibitors Overviews of clinical tria…

1
Simplifying HBV Screening and Care: Paths to Elimination 19:46

2M ago19:46

19:46

In this episode, Patricia D. Jones, MD, MSCR; Mindie H. Nguyen, MD, MAS, AGAF, FAASLD; and patient advocate, Jennifer Wild, MS, RN, OCN, discuss practical strategies to overcome barriers to hepatitis B virus (HBV) care, including: Overcoming health insurance navigation Improving access to HBV care in immigrant communities Dispelling HBV myths and s…

1
Best Practices for Inpatient Management of Severe COVID-19 15:18

2M ago15:18

15:18

In this episode, Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss: Workup of COVID-19 in the emergency department Methods of COVID-19 risk stratification Treatment recommendations for people with severe COVID-19, including how to effectively use antiviral therapy, dexamethasone, and other immunomodulato…

1
Leading Through Disorder: How Senior Communicators Are Navigating 2025's Perfect Storm 8:27

2M ago8:27

8:27

As senior communicators face unprecedented challenges—from economic uncertainty to societal polarization—how are they adapting? In this episode of The New CCO: Brief, Mara Hedgecoth (APCO) and Bill Walsh (AARP) discuss the evolving role of CCOs, their growing influence in risk management and how they are shaping strategy in an increasingly complex …

1
The AI Advantage: How Top Communicators are Leading the Shift 28:30

2M ago28:30

28:30

AI is reshaping corporate communications—are you ready to lead the shift? In this episode of The New CCO, top comms leaders Megan Noel (Golin), Mike Marinello (J.P. Morgan Payments), and Dan Gaynor (Signal AI) share how AI is driving real impact. Learn how communicators are turning AI into a competitive advantage.…

1
Inpatient Treatment of Severe COVID-19 in Patients Who Are Immunocompromisedn People Who Are Immunocompromised 15:02

2M ago15:02

15:02

Listen in as Cristina Mussini, MD; Martin Witzenrath, MD, FERS; and Michele Bartoletti, MD, PhD, discuss best practices in managing people who are immunocompromised with COVID-19 in the hospital setting, including: COVID-19 burden among this population Initial workup to assess disease severity Summary of COVID-19 guideline recommendations A detaile…

1
Evaluating and Managing PBC Symptoms: Curbside Consults Podcast 18:43

2M ago18:43

18:43

In this podcast, listen as experts Alan Bonder, MD, AGAF, and Aparna Goel, MD, discuss how they assess the symptoms of primary biliary cholangitis (PBC) and explore how new therapeutic agents may help alleviate symptom burden. Topics include: Strategies and tools for assessing pruritus Nonpharmacologic and pharmacologic management of pruritus Secon…

1
Defining Nonresponse to PBC Treatment: Curbside Consults Podcast 18:55

2M ago18:55

18:55

How do you decide when to move from first-line to second-line treatment for primary biliary cholangitis (PBC)? In this podcast, listen as experts Alan Bonder, MD, AGAF, and Aparna Goel, MD, discuss this question and more, including: How and when to measure treatment response Evidence-based goals of therapy Considerations for second-line treatment N…

1
Expert Insights and FAQs on CDK4/6 Inhibitors in the Care of Today’s Patients With HR-Positive/HER2-Negative Breast Cancer 45:08

2M ago45:08

45:08

In this episode, Jame Abraham, MD, FACP; William J. Gradishar, MD, FACP, FASCO; and Laura Spring, MD, review key insights and frequently asked questions related to the CDK4/6 inhibitors used to treat patients with early and metastatic hormone receptor (HR)–positive/HER2-negative breast cancer from a live program held in January 2025. Key clinical p…

1
The Health Impacts of Physically Demanding Work 13:16

2M ago13:16

13:16

Do physically active occupations make for healthier workers? Not necessarily. In this episode, Dr. Avi Biswas, scientist at the Institute for Work and Health, shares recommendations for safe, practical physical activity designed to meet the diverse needs of workers.

1
PBC Perspectives: A Patient and HCP in Conversation 27:29

2M ago27:29

27:29

In this podcast, Sonal Kumar, MD, MPH, meets with patient advocate Maria Morais to discuss actionable steps that healthcare providers can incorporate into the care of people with primary biliary cholangitis (PBC). Listen as they discuss: The chronic nature of PBC Going beyond biochemical markers to assess and address symptoms such as fatigue and pr…

1
Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma: Key Updates From the Annual Hematology Meeting 20:01

3M ago20:01

20:01

In this episode, Shaji K. Kumar, MD, reviews key data on bispecific antibodies used to treat patients with relapsed/refractory multiple myeloma recently presented at the 2024 annual American Society of Hematology meeting, including: Early results with teclistamab combined with anti-CD38 therapy Real-world data with teclistamab including its use aft…

1
COVID-19 in the EU: Inpatient Treatment of Mild to Moderate COVID-19 in Patients Who Are Immunocompromised 13:27

3M ago13:27

13:27

In this episode, Martin Witzenrath, MD, FERS, and Michele Bartoletti, MD, PhD, discuss the management of mild to moderate COVID-19 in patients who are immunocompromised, including: Initial workup, which may include laboratory tests and/or imaging Latest data on the use of remdesivir or nirmatrelvir plus ritonavir for mild to moderate COVID-19, incl…

1
Liberal Arts in the Age of AI: The CCO's Unexpected Advantage 7:12

3M ago7:12

7:12

Introducing The New CCO: Brief, a shorter format podcast from Page. In this episode, we look to uncover the most powerful weapon in modern communications today. Spoiler: it isn't artificial intelligence—it's the distinctly human ability to draw insights from art, philosophy and science. Listen to find out why your liberal arts degree might just be …

1
Defining Best Practices in HBV Care 34:14

3M ago34:14

34:14

In this episode, Patricia D. Jones, MD, MSCR; Mindie H. Nguyen, MD, MAS, AGAF, FAASLD; and patient advocate, Jennifer Wild, MS, RN, OCN, discuss best practices in hepatitis B virus (HBV) care, including: 2023 CDC HBV screening recommendations Summary of guideline recommendations for hepatitis delta virus (HDV) screening Use of HDV reflex testing to…

1
COVID-19 in the EU: Current Trends and Risk Factors for Severe COVID-19 Progression 16:48

3M ago16:48

16:48

In this episode, Cristina Mussini, MD, Martin Witzenrath, MD, FERS, and Michele Bartoletti, MD, PhD, discuss: Current SARS-CoV-2 trends in the EU Risk factors for severe COVID-19 outcomes, including the spectrum of risk based on immune system status Factors that may affect vaccine efficacy in chronic lymphocytic leukemia and other lymphoid malignan…

1
Expert Guidance on Managing Axial Spondyloarthritis and Psoriatic Arthritis to Improve Patient Outcomes and Quality of Life 27:38

3M ago27:38

27:38

Listen in as rheumatology experts Alexis Ogdie, MD, MSCE, and Julia Swafford, PA-C, DFAAPA, discuss emerging therapies and strategies in managing patients with axial spondyloarthritis or psoriatic arthritis, including: The current treatment landscape (eg, small molecules, biologics) Risk factors to consider when prescribing JAK inhibitors Key consi…

1
Building Trust in a Globalized World: Data, AI and Human Connection 28:21

3M ago28:21

28:21

In a world of increasing complexity, building trust across cultures has never been more challenging—or essential. Shahar Silbershatz and Axel Löber share insights on how global CCOs can navigate cultural nuances, leverage AI and data and foster authentic stakeholder connections. Listen to the conversation to hear how human connection remains at the…

1
Consommation de substances, stigmatisation et dépendance chez les hommes travaillant dans des métiers spécialisés 15:14

4M ago15:14

15:14

La stigmatisation à l’égard de la consommation de substances influe sur la façon dont nous parlons aux personnes, sur les politiques que nous élaborons et sur la prestation des soins. Dans cet épisode, la Dre Theresa Tam, administratrice en chef de la santé publique du Canada, et Anne Tennier, présidente et première dirigeante du CCHST, discutent d…

1
Substance Use, Stigma and Addiction Among Men in Trades 12:27

4M ago12:27

12:27

Stigma surrounding substance use affects how we talk to individuals, the policies we develop, and how we provide care. In this episode, Dr. Theresa Tam, Chief Public Health Officer of Canada, and Anne Tennier, President and CEO of CCOHS, discuss ways we can reduce stigma and support men in the trades who are struggling.…

1
Clinical Highlights: Oral SERDs for Patients With HR+/HER2- ESR1-Mutated Advanced Breast Cancer 36:04

4M ago36:04

36:04

In this episode, listen to Virginia Kaklamani, MD, DSc; Erica L. Mayer, MD, MPH; and Laura M. Spring, MD, share their clinical insights and takeaways from a live symposium, including from key abstracts presented at the 2024 San Antonio Breast Cancer Symposium: Estrogen receptor mutations in patients With HR-positive/HER2-negative advanced breast ca…

1
Simplified HCV Care in Sexual and Reproductive Health Clinics 1:04:44

4M ago1:04:44

1:04:44

In this episode, Tzu-Hao (Howard) Lee, MD; Tatyana Kushner, MD, MSCE; and patient advocate Andrew Reynolds discuss hepatitis C virus (HCV) care in men who have sex with men and pregnant people, including: HCV disease burden in the United States Screening recommendations Strategies to overcome barriers to HCV screening Treatment recommendations, inc…

1
Key PBC Studies From AASLD 2024 20:16

4M ago20:16

20:16

In this episode, Sonal Kumar, MD, MPH, discusses key findings from primary biliary cholangitis (PBC) studies presented at AASLD 2024, including: ELATIVE, a phase III trial of elafibranor for PBC RESPONSE, a phase III trial of seladelpar for PBC ASSURE, another phase III trial of seladelpar for PBC Presenter: Sonal Kumar, MD, MPH Director, Clinical …

1
Key PBC Studies From AASLD 2024 20:16

4M ago20:16

20:16

In this episode, Sonal Kumar, MD, MPH, discusses key findings from primary biliary cholangitis (PBC) studies presented at AASLD 2024, including: ELATIVE, a phase III trial of elafibranor for PBC RESPONSE, a phase III trial of seladelpar for PBC ASSURE, another phase III trial of seladelpar for PBC Presenter: Sonal Kumar, MD, MPH Director, Clinical …

1
Understanding Current Trends and Risk Factors for Progression to Severe COVID-19 16:01

4M ago16:01

16:01

Listen in as Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss current trends in and risk factors for progression to severe COVID-19, including for those for whom COVID-19 is not their primary concern when presenting to the emergency department (ED). Key topics of discussion include: How to complete a co…

Podcastok, amelyeket érdemes meghallgatni

CCO Podcastok

Podcastok, amelyeket érdemes meghallgatni

Gyors referencia kézikönyv